Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Pain

1594

Pain is a complex, multidimensional phenomenon. The understanding of this phenomenon is evolving as scientists from many disciplines conduct research. Increased knowledge provides health care professionals with many strategies for pain management. Pain is defined as whatever the person experiencing the pain says it is, existing whenever the person says it does. This clinical definition recognizes pain as a personal private experience.
Scientists at the International Association for the Study of Pain (IASP) have proposed another definition. This definition states that pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or it is described in terms of such damage.

In considering the IASP definition, it is important to note that not all potentially tissue-damaging stimuli result in pain. Nociception is the activation of the primary afferent nerves with peripheral terminals that respond differently to noxious stimuli. Nociceptors function primarily to sense and transmit pain signals. Nociception may or may not be perceived as pain, depending on a complex interaction within the nociceptive pathways. If nociceptive stimuli are blocked, pain is not perceived. Finally, it is important to distinguish pain, or nociception, from suffering. Suffering is the state of severe distress associated with events that threaten the intactness of the person. Suffering is an emotion. Pain and suffering are not the same phenomenon.

The person who complained of pain in the heart because of the death of a loved one is suffering rather than experiencing pain as it is defined by the IASP. It is clear that three conditions could exist: 1) suffering occurs in the presence of pain,2) suffering occurs when pain is not present, and 3) pain occurs when suffering is not present. For example, the woman awaiting breast biopsy may suffer because of anticipated loss of her breast. After the biopsy, she may have pain without suffering if the biopsy is negative or pain with suffering if the biopsy is positive for malignancy. Interventions aimed at relieving pain and suffering may have some commonalities, but clearly some interventions for suffering will be inadequate for pain just as some interventions for pain are inadequate for suffering.

RSS Feeds

All reports in Pain

< prev 1  2  3  4  5  6  7  8  9  next >
Tension -Type Headache Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
... provides elemental information and data relating to the clinical trials on Tension -Type Headache. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ...  |  more...
$1,000.00
Complex Regional Pain Syndrome Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
... scenario. This report provides elemental information and data relating to the clinical trials on Complex Regional Pain Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of ...  |  more...
$1,000.00
Dental Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Dental Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Osteoarthritis Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Osteoarthritis Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Cancer Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Cancer Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Inflammatory Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Inflammatory Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Joint Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Joint Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Musculoskeletal Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Musculoskeletal Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Post-Operative Pain Global Clinical Trials Review, H1, 2012
3/31/2012 | published by: GlobalData
... and data relating to the clinical trials on Post-Operative Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Back Pain – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Back Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Back Pain. 'Back Pain - Pipeline Review, H1 2012' ...  |  more...
$500.00
Cancer Pain – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Cancer Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cancer Pain. 'Cancer Pain - Pipeline Review, H1 2012' ...  |  more...
$500.00
Musculoskeletal Pain – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Musculoskeletal Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Musculoskeletal Pain. 'Musculoskeletal Pain - Pipeline Review, H1 2012' ...  |  more...
$500.00
Pain Management, 2nd edition
3/1/2012 | published by: Apollo Managed Care Consultants
 |  more...
$75.00
Neuropathic Pain – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Neuropathic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuropathic Pain. 'Neuropathic Pain - Pipeline Review, H1 2012' ...  |  more...
$500.00
Osteoarthritis Pain – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Osteoarthritis Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Osteoarthritis Pain. 'Osteoarthritis Pain - Pipeline Review, H1 2012' ...  |  more...
$500.00
Acute Pain – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Acute Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Pain. 'Acute Pain - Pipeline Review, H1 2012' ...  |  more...
$500.00
Evolution in the Pain Therapy Drugs Market:
1/5/2012 | published by: Espicom Healthcare Intelligence
... of the population suffers from chronic pain. As the population ages, the number of people with chronic pain is increasing, particularly from conditions such as osteoarthritis. Chronic pain is also associated with cancer. An estimated ...  |  more...
$2,265.00
Joint Pain Global Clinical Trials Review, H2, 2011
11/30/2011 | published by: GlobalData
... and data relating to the clinical trials on Joint Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...  |  more...
$1,000.00
Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
11/30/2011 | published by: GlobalData
... “Russian Federation Anesthesia and Respiratory Devices Market Outlook to 2017 - Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others” provides key market data ...  |  more...
$2,500.00
Ocular Pain - Pipeline Review, H2 2011
11/28/2011 | published by: Global Markets Direct
... for Ocular Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ocular Pain. 'Ocular Pain - Pipeline Review, H2 2011' ...  |  more...
$500.00
Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta
11/22/2011 | published by: GBI Research
... to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and Cymbalta”, which provides insights into the global pain management therapeutics market and market forecasts until 2017. The report provides an in-depth analysis ...  |  more...
$3,500.00
Analgesics in Saudi Arabia
11/9/2011 | published by: Euromonitor International
... affordable product pricing, a wide product variety and widespread distribution among both chemists/pharmacies and grocery retailers. This product area also benefits from the strong and longstanding presence of multinational brands such as GlaxoSmithKline’s Panadol... Euromonitor ...  |  more...
$900.00
Physician Attitudes Regarding The Risks, Safe Use, And Regulations Of Long-acting Or Extended-release Opioids For Patients With Chronic Pain
11/1/2011 | published by: CE Outcomes
... of opioid-prescribing and education regulations. This paper presents initial data on the factors involved in the decision-making process of initiating a conversation about the risks and safe use of long-acting and extended-release (LA/ER) opioids. Additionally, ...  |  more...
$14,000.00
Migraine Global Clinical Trials Review, H2, 2011
10/30/2011 | published by: GlobalData
... to the clinical trials on Migraine. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of ...  |  more...
$1,000.00
Back Pain - Pipeline Review, H2 2011
10/26/2011 | published by: Global Markets Direct
... for Back Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Back Pain. 'Back Pain - Pipeline Review, H2 2011' ...  |  more...
$500.00
< prev 1  2  3  4  5  6  7  8  9  next >